Diane Bodenmiller

Hepatic and glucagon-like peptide-1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors

Kyle W. Sloop, Julia X.C. Cao, Angela M. Siesky et al. · Journal of Clinical Investigation · 2004 · 210 citations · Full text

The <i>yjeB</i> ( <i>nsrR</i> ) Gene of <i>Escherichia coli</i> Encodes a Nitric Oxide-Sensitive Transcriptional Regulator

Diane Bodenmiller, Stephen Spiro · Journal of Bacteriology · 2006 · 205 citations · Full text

Targeted suppression of an amyloidogenic transthyretin with antisense oligonucleotides

Merrill D. Benson, Barbara Kluve‐Beckerman, Steven R. Zeldenrust et al. · Muscle & Nerve · 2006 · 146 citations

NsrR targets in the <i>Escherichia coli</i> genome: new insights into DNA sequence requirements for binding and a role for NsrR in the regulation of motility

Jonathan D. Partridge, Diane Bodenmiller, Michael S. Humphrys et al. · Molecular Microbiology · 2009 · 142 citations · Full text

Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism

Lynnetta M. Watts, Vara Prasad Manchem, Thomas A. Leedom et al. · Diabetes · 2005 · 136 citations · Full text

Glucocorticoid, Insulin Signaling, Gastrointestinal Peptide Hormone +16